Cannabis Science (CBIS) Purchases Two Parcels of Cannabis Production Land from Apothecary Genetics, a Combined Total of 51 Acres; Licenses Land, Cultivation, and Formulation Usage in Major Growth Plan in California
| Monday, November 24, 2014 8:15 AM |

[PR Newswire] - COLORADO SPRINGS, Colo., Nov. 24, 2014 /PRNewswire/ -- In a move that signals a forceful reinvestment in the largest legal medical cannabis market, Cannabis Science, Inc. (CBIS), a U.S. company specializing in global cannabis formulation-based drug development and consulting, has successfully renegotiated its agreement with Apothecary Genetics Investments LLC to purchase and license two northern California production farms with a combined total of 51 acres. The purchase includes all related equipment for cannabis cultivation and production for the state's substantial medical cannabis market.

http://us.rd.yahoo.com/finance/news/rss/story...00217.html

~ This Week's OTC News In Review! ~

Covering the entire market and teaching traders! Visit here to learn technicals and fundamentals >>
http://www.stockgoodies.com/lessons.html


~ http://www.fallenheroesfund.org/ ~
St. Jude 2014 Drive has started >> http://tinyurl.com/St-Jude-2014